Dr Sarah Kidd
Adjunct Senior Lecturer
School of Biological Sciences
Faculty of Sciences
Sarah Kidd is Head of the National Mycology Reference Centre at SA Pathology, Adelaide, as well as adjunct staff at both the University of Adelaide and University of South Australia. She completed a Bachelor of Medical Science with Honours and a PhD in Medicine, both at the University of Sydney, and is a Fellow of the Australian Society for Microbiology. She has undertaken postdoctoral training and research in medical mycology at the University of British Columbia, Vancouver, Canada, and at Monash University at The Alfred Hospital, Melbourne. Research interests include the epidemiology, phylogeny, and antifungal susceptibilities of fungi, in particular Aspergillus and Cryptococcus species.
Please note correct email address: SARAH.KIDD@SA.GOV.AU
-
Expand
-
Appointments
Date Position Institution name 2012 Adjunct Senior Lecturer University of Adelaide 2011 Head, National Mycology Reference Centre SA Pathology 2006 - 2010 Postdoctoral Research Scientist Monash University, Melbourne 2003 - 2006 Postdoctoral Research Scientist University of British Columbia -
Awards and Achievements
Date Type Title Institution Name Country Amount 2018 Fellowship Fellowship of the Australian Society for Microbiology Australian Society for Microbiology Australia — -
Education
Date Institution name Country Title 2000 - 2003 University of Sydney Australia PhD 1996 - 1999 University of Sydney Australia Bachelor of Medical Science (Hons.) -
Postgraduate Training
Date Title Institution Country 2006 - 2010 Research Fellow Monash University, Alfred Hospital Australia 2003 - 2006 Postdoctoral Research Fellow University of British Columbia Canada -
Research Interests
-
Expand
-
Journals
Year Citation 2018 Kidd, S., Halliday, C., Morris, A., & Chen, S. (2018). Antifungal susceptibility testing in Australasian clinical laboratories: we must improve our performance. Pathology, 50(3), 257-260.
DOI2018 Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Dannaoui, E., Garcia-Effron, G., Guinea, J., . . . Tortorano, A. (2018). Posaconazole MIC distributions for aspergillus fumigatus species complex by four methods: Impact of cyp51a mutations on estimation of epidemiological cutoff values. Antimicrobial Agents and Chemotherapy, 62(4), 11 pages.
DOI Scopus2 WoS2 Europe PMC12018 Bennett, P., Talbot, J., Martin, P., Kidd, S., Makara, M., & Barrs, V. (2018). Long term survival of a dog with disseminated Aspergillus deflectus infection without definitive treatment. Medical Mycology Case Reports, 22, 1-3.
DOI2018 Marinelli, T., Kidd, S., Shaw, D., & Rowe, E. (2018). Aspergillus fumigatus endocarditis in an indigenous Australian male without classic risk factors. Medical Mycology Case Reports, 22, 61-64.
DOI2017 Talbott, J., Houbraken, J., Frisvad, J., Samson, R., Kidd, S., Pitt, J., . . . Barrs, V. (2017). Discovery of Aspergillus frankstonensis sp. nov. during
environmental sampling for animal and human fungal pathogens. PLoS ONE, 12(8), e0181660-1-e0181660-17.
DOI Scopus2 WoS1 Europe PMC12017 Espinel-Ingroff, A., Abreu, D., Almeida-Paes, R., Brilhante, R., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). Multicenter, International Study of MIC/ MEC Distributions for definition of epidemiological cutoff values for sporothrix species identified by molecular methods. Antimicrobial Agents and Chemotherapy, 61(10), e01057-17-1-e01057-17-8.
DOI Scopus7 Europe PMC22017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Changing epidemiology of candidaemia in Australia.. The Journal of antimicrobial chemotherapy, 72(4), 1103-1108.
DOI Scopus19 WoS20 Europe PMC42017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422. Journal of Antimicrobial Chemotherapy, 72(4), 1270.
DOI Scopus6 WoS3 Europe PMC162016 Lategan, M., Klare, W., Kidd, S., Hose, G., & Nevalainen, H. (2016). The unicellular fungal tool RhoTox for risk assessments in groundwater systems. Ecotoxicology and Environmental Safety, 132, 18-25.
DOI Scopus1 WoS1 Europe PMC12016 McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia. BMC Infectious Diseases, 16(1), 1-7.
DOI Scopus4 WoS4 Europe PMC62016 Morton, C., White, P., Barnes, R., Klingspor, L., Cuenca-Estrella, M., Lagrou, K., . . . Loeffler, J. (2016). Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus ?. Medical Mycology, 55(4), myw093.
DOI Scopus5 Europe PMC42016 Morris, A., Arthur, I., Kidd, S., Halliday, C., Meyer, W., Robson, J., . . . Haremza, E. (2016). Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvement. Pathology, 48(6), 531-534.
DOI WoS1 Europe PMC12016 Kennedy, K., Daveson, K., Slavin, M., van Hal, S., Sorrell, T., Lee, A., . . . Chen, S. (2016). Mucormycosis in Australia: Contemporary epidemiology and outcomes. Clinical Microbiology and Infection, 22(9), 775-781.
DOI Scopus16 WoS13 Europe PMC112016 Espinel-Ingroff, A., Colombo, A., Cordoba, S., Dufresne, P., Fuller, J., Ghannoum, M., . . . Turnidge, J. (2016). International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrobial Agents and Chemotherapy, 60(2), 1079-1084.
DOI Scopus40 WoS31 Europe PMC262016 Halliday, C., Chen, S., Kidd, S., van Hal, S., Chapman, B., Heath, C., . . . Slavin, M. (2016). Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. International Journal of Antimicrobial Agents, 48(4), 453-458.
DOI Scopus5 WoS5 Europe PMC32015 Slavin, M., van Hal, S., Sorrell, T., Lee, A., Marriott, D., Daveson, K., . . . Chambers, S. (2015). Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clinical Microbiology and Infection, 21(5), 490.e1-490.e10.
DOI Scopus37 Europe PMC262015 Halliday, C., Kidd, S., Sorrell, T., & Chen, S. (2015). Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?. Pathology, 47(3), 257-269.
DOI Scopus22 WoS18 Europe PMC122015 van der Linden, J., Arendrup, M., Warris, A., Lagrou, K., Pelloux, H., Hauser, P., . . . Verweij, P. (2015). Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21(6), 1041-1044.
DOI Scopus109 WoS98 Europe PMC822015 Espinel-Ingroff, A., & Kidd, S. (2015). Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infection and Drug Resistance, 8, 89-97.
DOI Scopus18 WoS17 Europe PMC172015 Talbot, J., Kidd, S., Martin, P., Beatty, J., & Barrs, V. (2015). Azole resistance in canine and feline isolates of Aspergillus fumigatus. Comparative Immunology, Microbiology and Infectious Diseases, 42, 37-41.
DOI Scopus6 WoS5 Europe PMC52015 Kidd, S., Goeman, E., Meis, J., Slavin, M., & Verweij, P. (2015). Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses, 58(6), 350-355.
DOI Scopus45 WoS42 Europe PMC392015 Gardiner, B., Simpson, I., Khuu, M., Kidd, S., Lo, C., & Jenkin, G. (2015). An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae. Medical Mycology Case Reports, 7, 8-11.
DOI Scopus1 Europe PMC12015 Espinel-Ingroff, A., Chakrabarti, A., Chowdhary, A., Cordoba, S., Dannaoui, E., Dufresne, P., . . . Turnidge, J. (2015). Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrobial Agents and Chemotherapy, 59(3), 1745-1750.
DOI Scopus28 WoS23 Europe PMC202015 Espinel-Ingroff, A., Alvarez-Fernandez, M., Cantón, E., Carver, P., Chen, S., Eschenauer, G., . . . Turnidge, J. (2015). Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrobial Agents and Chemotherapy, 59(11), 6725-6732.
DOI Scopus28 WoS25 Europe PMC222015 Brischetto, A., Kidd, S., & Baird, R. (2015). Case report: First reported Australian case of Cladophilophora arxii: Features consistent with possible primary pulmonary chromoblastomycosis. American Journal of Tropical Medicine and Hygiene, 92(4), 791-793.
DOI Scopus1 WoS2 Europe PMC22015 Khoury, S., Kidd, S., & Warren, L. (2015). Neonatal tinea corporis due to a novel strain of Trichophyton rubrum. Australasian Journal of Dermatology, 56(4), 311-312.
DOI Scopus3 WoS3 Europe PMC22015 Kidd, S., Halliday, C., & Ellis, D. (2015). The role of clinical mycology reference laboratories. Microbiology Australia, 36(2), 64-66.
DOI2014 Subedi, S., Kidd, S., Baird, R., Coatsworth, N., & Ralph, A. (2014). Case Report: Sporotrichosis from the northern territory of Australia. American Journal of Tropical Medicine and Hygiene, 91(6), 1263-1268.
DOI Scopus3 WoS5 Europe PMC32014 Macesic, N., Fleming, S., Kidd, S., Madigan, V., Chean, R., Ritchie, D., & Slavin, M. (2014). Protothecosis in hematopoietic stem cell transplantation: Case report and review of previous cases. Transplant Infectious Disease, 16(3), 490-495.
DOI Scopus11 WoS9 Europe PMC72014 Talbot, J., Johnson, L., Martin, P., Beatty, J., Sutton, D., Billen, F., . . . Barrs, V. (2014). What causes canine sino-nasal aspergillosis? A molecular approach to species identification. Veterinary Journal, 200(1), 17-21.
DOI Scopus10 WoS9 Europe PMC72014 Coad, B., Kidd, S., Ellis, D., & Griesser, H. (2014). Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. Biotechnology Advances, 32(2), 296-307.
DOI Scopus32 WoS32 Europe PMC112013 Chen, S., Korman, T., Slavin, M., Marriott, D., Byth, K., Bak, N., . . . Sorrell, T. (2013). Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clinical Infectious Diseases, 57(4), 543-551.
DOI Scopus54 WoS45 Europe PMC362013 Barrs, V., van Doorn, T., Houbraken, J., Kidd, S., Martin, P., Pinheiro, M., . . . Samson, R. (2013). Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE, 8(6), e64871-1-e64871-11.
DOI Scopus53 WoS46 Europe PMC352013 Holmes, N., Trevillyan, J., Kidd, S., & Leong, T. (2013). Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma. Medical Mycology Case Reports, 2(1), 98-102.
DOI Scopus7 Europe PMC62012 Bartlett, K., Cheng, P., Duncan, C., Galanis, E., Hoang, L., Kidd, S., . . . Kronstad, J. (2012). A Decade of Experience: Cryptococcus gattii in British Columbia. Mycopathologia, 173(5-6), 311-319.
DOI Scopus40 WoS36 Europe PMC282012 Chen, S., Slavin, M., Heath, C., Geoffrey Playford, E., Byth, K., Marriott, D., . . . Sorrell, T. (2012). Clinical manifestations of cryptococcus gattii infection: Determinants of neurological sequelae and death. Clinical Infectious Diseases, 55(6), 789-798.
DOI Scopus79 WoS71 Europe PMC572012 Espinel-Ingroff, A., Aller, A., Canton, E., Castanon-Olivares, L., Chowdhary, A., Cordoba, S., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole. Antimicrobial Agents and Chemotherapy, 56(11), 5898-5906.
DOI Scopus111 WoS103 Europe PMC872012 Espinel-Ingroff, A., Chowdhary, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Hagen, F., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine. Antimicrobial Agents and Chemotherapy, 56(6), 3107-3113.
DOI Scopus61 WoS55 Europe PMC492011 D'Souza, C., Kronstad, J., Taylor, G., Warren, R., Yuen, M., Hu, G., . . . Cuomoe, C. (2011). Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. mBio, 2(1), 11 pages.
DOI Scopus83 WoS87 Europe PMC762010 Galanis, E., Macdougall, L., Kidd, S., Morshed, M., & British Columbia Cryptococcus gattii Working Group. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.. Emerging infectious diseases, 16(2), 251-257.
DOI Europe PMC1012010 Galanis, E., & MacDougall, L. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. EMERGING INFECTIOUS DISEASES, 16(2), 251-257.
DOI WoS1242009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
DOI WoS149 Europe PMC1152009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
DOI WoS149 Europe PMC1152009 Kidd, S., Ling, L., Meyer, W., Morrissey, C., Chen, S., & Slavin, M. (2009). Molecular epidemiology of invasive aspergillosis: Lessons learned from an outbreak investigation in an Australian hematology unit. Infection Control and Hospital Epidemiology, 30(12), 1223-1226.
DOI Scopus9 WoS9 Europe PMC62009 Kidd, S., Nik Zulkepeli, N., Slavin, M., & Morrissey, C. (2009). Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications. Journal of Microbiological Methods, 78(2), 223-226.
DOI Scopus12 WoS9 Europe PMC72009 Hurst, S., Kidd, S., Morrissey, C., Snelders, E., Melchers, W., Castelli, M., . . . Arunmozhi Balajee, S. (2009). Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus. Journal of Clinical Microbiology, 47(5), 1562-1564.
DOI Scopus12 WoS10 Europe PMC62008 Bartlett, K., Kidd, S., & Kronstad, J. (2008). The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1), 58-65.
DOI Scopus61 Europe PMC462007 Upton, A., Fraser, J., Kidd, S., Bretz, C., Bartlett, K., Heitman, J., & Marr, K. (2007). First contemporary case of human infection with Cryptococcus gattii in puget sound: Evidence for spread of the Vancouver Island outbreak. Journal of Clinical Microbiology, 45(9), 3086-3088.
DOI Scopus56 WoS55 Europe PMC472007 Kidd, S., Bach, P., Hingston, A., Mak, S., Chow, Y., MacDougall, L., . . . Bartlett, K. (2007). Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerging Infectious Diseases, 13(1), 51-57.
DOI Scopus78 WoS74 Europe PMC602007 MacDougall, L., Kidd, S., Galanis, E., Mak, S., Leslie, M., Cieslak, P., . . . Bartlett, K. (2007). Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerging Infectious Diseases, 13(1), 42-50.
DOI Scopus184 WoS164 Europe PMC1232007 Kidd, S., Chow, Y., Mak, S., Bach, P., Chen, H., Hingston, A., . . . Bartlett, K. (2007). Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Applied and Environmental Microbiology, 73(5), 1433-1443.
DOI Scopus138 WoS136 Europe PMC1122006 Filion, T., Kidd, S., & Aguirre, K. (2006). Isolation of Cryptococcus laurentii from Canada Goose guano in rural upstate New York. Mycopathologia, 162(5), 363-368.
DOI Scopus10 WoS9 Europe PMC62005 Kidd, S., Guo, H., Bartlett, K., Xu, J., & Kronstad, J. (2005). Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryotic Cell, 4(10), 1629-1638.
DOI Scopus81 WoS87 Europe PMC652004 Kidd, S., Hagen, F., Tscharke, R., Huynh, M., Bartlett, K., Fyfe, M., . . . Meyer, W. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17258-17263.
DOI Scopus486 WoS458 Europe PMC3602004 Igreja, R., Dos Santos Lazéra, M., Wanke, B., Gutierrez Galhardo, M., Kidd, S., & Meyer, W. (2004). Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Medical Mycology, 42(3), 229-238.
DOI Scopus38 WoS38 Europe PMC352004 Katsu, M., Kidd, S., Ando, A., Moretti-Branchini, M., Mikami, Y., Nishimura, K., & Meyer, W. (2004). The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research, 4(4-5), 377-388.
DOI Scopus82 WoS87 Europe PMC682003 Kidd, S., Sorrell, T., & Meyer, W. (2003). Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Medical Mycology, 41(2), 171-176.
DOI Scopus28 WoS26 Europe PMC17 -
Books
Year Citation 2016 Kidd, S., Halliday, C., Alexiou, H., & Ellis, D. (2016). Descriptions of Medical Fungi Third Edition. -
Book Chapters
Year Citation 2017 Halliday, C., & Kidd, S. E. (2017). Cryptococcus. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology. UK: Oxford University Press. 2017 Kidd, S. E., & Halliday, C. H. (2017). Dematiaceous fungi. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology. UK: Oxford University Press. 2011 Bartlett, K., Byrnes, E., Duncan, C., Fyfe, M., Galanis, E., Heitman, J., . . . Kronstad, W. (2011). The Emergence of Cryptococcus gattii Infections on Vancouver Island and Expansion in the Pacific Northwest. In J. Heitman, T. Kozel, K. Kwon-Chung, J. Perfect, & A. Casadevall (Eds.), Cryptococcus: From Human Pathogen to Model Yeast. USA: ASM Press.
DOI -
Conference Papers
Year Citation 2012 Chen, S., Slavin, M., Heath, C., Playford, E., Byth, K., Marriott, D., . . . Sorrell, T. (2012). Cryptococcus gattii infection: Long term morbidity and determinants of neurological sequelae and death. In MYCOSES Vol. 55 (pp. 78). WILEY-BLACKWELL. 2004 Bartlett, K., MacDougall, L., Mak, S., Duncan, C., Kidd, S., & Fyfe, M. (2004). Cryptococcus gattii, a tropical pathogen emerging in a temperate climate zone. In 16th Conference on Biometeorology and Aerobiology (pp. 39-43). -
Conference Items
Year Citation 2013 Birader, M., Kidd, S., & Holmes-Liew, C. -L. (2013). OPTIMAL UTILITY OF BAL FLUID GALACTOMANNAN IN DIAGNOSING INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. 2013 Birader, M. I., Holmes, M. D., Kidd, S., & Holmes-Liew, C. L. (2013). Utility of bronchoalveolar lavage galactomannan in diagnosis of Aspergillosis in lung transplant recipients. Poster session presented at the meeting of Abstracts from the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, as published in Journal of Heart and Lung Transplantation. Montreal, Canada: Elsevier.
DOI -
Theses
Year Citation 2003 Kidd, S. (2003). Molecular epidemiology and characterisation of genetic structure to assess speciation within the Cryptococcus neoformans complex. (PhD Thesis, University of Sydney). -
Internet Publications
Year Citation 2014 Kidd, S. E., & ellis, D. (2014). Australian Antifungal Susceptibility Trends in Yeasts: 2000-2013.. Australian Society of Antimicrobials.
-
Expand
-
Committee Memberships
Date Role Committee Institution Country 2016 - ongoing Chair Mycology Masterclass VI, Oct 26-28 2017 ANZMIG Australia 2012 - 2017 Co-Chair Organising Committee, ISHAM Conference, Melbourne May 4-8 2015 ANZMIG Australia 2012 - 2013 Chair Mycology Masterclass VI, Oct 31-Nov 2 2013 ANZMIG Australia 2011 - ongoing Advisory Board Member RCPA QAP Microbiology Royal College of Pathologists Quality Assurance Program Australia 2011 - ongoing Secretary Australia New Zealand Mycoses Interest Group (ANZMIG) Australasian Society for Infectious Diseases Australia 2011 - 2013 Member ASM Conference Local Organising Committee, Adelaide 2013 ASM Australia 2010 - 2011 Co-Chair Mycology Masterclass V, 27-29 October 2011 ANZMIG Australia -
Memberships
Date Role Membership Country 2018 - ongoing Member Australian Society for Antimicrobials Australia 2012 - ongoing Member International Society for Human and Animal Mycology — 2011 - ongoing Member Australasian Society for Infectious Diseases (ASID) Australia 2001 - ongoing Member Australian Society for Microbiology Australia -
Consulting/Advisories
Date Institution Department Organisation Type Country 2018 - ongoing ASA EUCAST National AST Committee (AusNAC) - Scientific research Australia 2017 - ongoing National Association of Testing Authorities — Health services and related Australia 2016 - ongoing International Accreditation New Zealand (IANZ) — Health services and related New Zealand 2015 - ongoing Merck Sharp & Dohme — Health services and related Australia 2014 - ongoing Mayne Pharma — Health services and related Australia 2011 - ongoing Pfizer Anti-infectives — Health services and related Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2018 - ongoing Editor Journal of Medical Microbiology Microbiology Society United Kingdom
Connect With Me
External Profiles
